We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
+7.58%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$2.41B
AUM Growth
-$3.75B
Cap. Flow
-$4.09B
Cap. Flow %
-169.35%
Top 10 Hldgs %
31.78%
Holding
6,989
New
537
Increased
1,703
Reduced
3,620
Closed
686

Sector Composition

Rank Sector Weight
1 Technology 21.71%
2 Healthcare 7.7%
3 Consumer Discretionary 6.83%
4 Financials 6.52%
5 Industrials 4.92%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TBHC
5201
DELISTED
The Brand House Collective
TBHC
$3K ﹤0.01%
891
+821
+1,173% +$3.02K
KXI icon
5202
iShares Global Consumer Staples ETF
KXI
$1.07B
$3K ﹤0.01%
54
+28
+108% +$1.62K
LARK icon
5203
Landmark Bancorp
LARK
$196M
$3K ﹤0.01%
130
+123
+1,757% +$2.56K
LGVN
5204
Longeveron
LGVN
$21.8M
$3K ﹤0.01%
99
-43
-30% -$1.53K
NMAD
5205
Nomad Power Solutions
NMAD
$74.6M
$3K ﹤0.01%
674
-18
-3% -$100
LTBR icon
5206
Lightbridge
LTBR
$326M
$3K ﹤0.01%
668
-729
-52% -$3.43K
LUCD icon
5207
Lucid Diagnostics
LUCD
$184M
$3K ﹤0.01%
2,561
-4,721
-65% -$8.49K
MEC icon
5208
Mayville Engineering Co
MEC
$593M
$3K ﹤0.01%
305
-4,218
-93% -$42.1K
MFLX icon
5209
First Trust Exchange-Traded Fund VIII First Trust Flexible Municipal High Income ETF
MFLX
$21.2M
$3K ﹤0.01%
175
-22
-11% -$352
MGTX icon
5210
MeiraGTx Holdings
MGTX
$1.17B
$3K ﹤0.01%
494
-3,992
-89% -$27.4K
MJ icon
5211
Amplify Alternative Harvest ETF
MJ
$113M
$3K ﹤0.01%
61
-419
-87% -$25.9K
DFTX
5212
Definium Therapeutics
DFTX
$5.91B
$3K ﹤0.01%
1,311
-48
-4% -$133
MRIN
5213
DELISTED
Marin Software
MRIN
$3K ﹤0.01%
+503
New +$3.5K
NOTE
5214
DELISTED
FiscalNote
NOTE
$3K ﹤0.01%
41
-192
-82% -$13K
NXE icon
5215
NexGen Energy
NXE
$6.96B
$3K ﹤0.01%
773
-37,267
-98% -$155K
ORBS
5216
Eightco Holdings
ORBS
$294M
$3K ﹤0.01%
73
+16
+28% +$1.81K
ONON icon
5217
On Holding
ONON
$10.5B
$3K ﹤0.01%
184
-32,250
-99% -$564K
PAY icon
5218
Paymentus
PAY
$5.32B
$3K ﹤0.01%
383
+376
+5,371% +$3.69K
PROV icon
5219
Provident Financial
PROV
$113M
$3K ﹤0.01%
190
+34
+22% +$481
CNSY
5220
Cerenome, Inc. Common Stock
CNSY
$25.5M
$3K ﹤0.01%
24
-2
-8% -$318
PW
5221
Power REIT
PW
$2.93M
$3K ﹤0.01%
78
+14
+22% +$1.02K
PXLW icon
5222
Pixelworks
PXLW
$45.6M
$3K ﹤0.01%
125
+119
+1,983% +$2.13K
RKDA icon
5223
Arcadia Biosciences
RKDA
$1.16M
$3K ﹤0.01%
269
-13
-5% -$185
RMR icon
5224
The RMR Group
RMR
$344M
$3K ﹤0.01%
119
-3,366
-97% -$91.5K
SBIO icon
5225
ALPS Medical Breakthroughs ETF
SBIO
$215M
$3K ﹤0.01%
100
-22,456
-100% -$676K

Similar funds

Tower Research Capital (TRC)'s Q4 2022 Portfolio in Review

As of Q4 2022, Tower Research Capital (TRC) held 6,989 positions worth $2.41B, down 61% from $6.16B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Tower Research Capital (TRC) withdrew a net $4.09B in Q4 2022, closing 686 positions and reducing 3,620 holdings. Its most notable exit was Vanguard Russell 2000 Value ETF, an estimated $4.46M position sold in full.

By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 27% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, Tower Research Capital (TRC) opened a new position in iShares Semiconductor ETF worth $9.33M.

  • Tower Research Capital (TRC)'s largest Q4 2022 buy was iShares Semiconductor ETF: 80,454 shares worth $9.33M.
  • Tower Research Capital (TRC) added most to iShares Russell 2000 ETF in Q4 2022, an estimated $145M increase.
  • Tower Research Capital (TRC)'s biggest Q4 2022 reduction was Apple, cutting an estimated $322M.
  • Tower Research Capital (TRC) fully exited Vanguard Russell 2000 Value ETF in Q4 2022, selling an estimated $4.46M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 32% of its $2.41B portfolio in Q4 2022.
  • Tower Research Capital (TRC) opened 537 new positions and closed 686 in Q4 2022.
  • Tower Research Capital (TRC)'s portfolio value fell 61% quarter-over-quarter to $2.41B.

Based on Tower Research Capital (TRC)'s 13F filing for Q4 2022, filed 10 Feb 2023.